slides · global inventory
Traction
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,471
Current window 4,741-4,770
Pages 350
Rows per page 30
Slide type
4,741-4,770 of 10,471
14
The slide details the dosing regimens for different cohorts over induction and consolidation phases.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
15
The slide uses a process-flow diagram to present five key clinical findings.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
18
Each patient is represented by a timeline showing rapid decline in fungal load from screening to final visit day.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
19
Matinas BioPharma | Investor Presentation Deck | 31 slidesMatinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
25
The slide highlights clinical safety and pharmacokinetic success for an oral formulation of amikacin.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
26
Data presented as three distinct charts: line graph for weight, dot plot for congestion, and dot plot for viral titers.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
27
The slide highlights a $2.75M upfront payment and the strategic synergy between Matinas' LNC platform and BioNTech's mRNA expertise.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
09
The slide uses a mix of bullet points and checkmarks to categorize technical achievements and market opportunities.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations Loop · Voice Of Customer1 hit
13
The slide uses a before-after-bridge structure to demonstrate therapeutic efficacy.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
14
Includes longitudinal patient data and representative imaging.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
20
The slide displays two line charts comparing PAX-101 against placebo across multiple time points, with error bars indicating standard error.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
22
The slide uses a human-centric image to emphasize the clinical impact of the drug.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
07
The slide presents three dot plots comparing Vehicle, MPLA, PHAD, 3D PHAD, and 3D 6-Acyl PHAD treatments.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Zoom In1 hit
08
Includes three dot plots for bacterial clearance (Lung, Spleen, Kidney) and one Kaplan-Meier survival curve.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Zoom In1 hit
11
The slide uses a combination of line charts and bar charts to present clinical trial results.Revelation Biosciences | Investor Presentation Deck | 18 slides · Revelation Biosciences
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
05
Includes detailed footnotes explaining the basis of the metrics and financial outlook.Skillsoft | Results Presentation Deck | 34 slides · Skillsoft
Pitch deck Investor relations Loop · Pattern Hunter1 hit
11
The chart illustrates the shift in ARR distribution from single-product customers to multi-product customers between 4Q19 and 4Q22.Skillsoft | Results Presentation Deck | 34 slides · Skillsoft
Pitch deck Investor relations Loop · Pattern Hunter1 hit
19
The slide highlights the additive nature of the merger, showing how the two companies complement each other's existing customer bases.Skillsoft | Results Presentation Deck | 34 slides · Skillsoft
Pitch deck Investor relations Loop · Pattern Hunter1 hit
21
The slide uses a combination of key performance indicators (KPIs) and bar charts to illustrate growth trajectory.Skillsoft | Results Presentation Deck | 34 slides · Skillsoft
Pitch deck Investor relations Loop · Pattern Hunter1 hit
23
The slide uses a stacked bar chart to show the shift from legacy Skillport to Percipio/Dual deployment, supported by a data table for specific performance metrics.Skillsoft | Results Presentation Deck | 34 slides · Skillsoft
Pitch deck Investor relations Loop · Pattern Hunter1 hit
07
The slide uses a 2x5 grid layout to present company performance and market data.Stran & Company | Investor Presentation Deck | 31 slides · Stran & Company
Pitch deck Investor relations 1 hit
16
The slide uses a consistent template to compare three distinct acquisitions by STRÄN.Stran & Company | Investor Presentation Deck | 31 slides · Stran & Company
Pitch deck Investor relations 1 hit
18
The slide uses a 2x3 grid of icons with associated metrics.Stran & Company | Investor Presentation Deck | 31 slides · Stran & Company
Pitch deck Investor relations Beat · Financial Highlights1 hit
19
The chart uses a dual-bar structure per year to compare revenue and gross profit, with percentage labels for gross margin.Stran & Company | Investor Presentation Deck | 31 slides · Stran & Company
Pitch deck Investor relations Beat · Financial Highlights1 hit
20
The chart uses alternating blue and teal bars for annual data, with a distinct orange bar for the 2022 half-year figure.Stran & Company | Investor Presentation Deck | 31 slides · Stran & Company
Pitch deck Investor relations Beat · Financial Highlights1 hit
23
The slide uses a timeline framework to demonstrate long-term client retention and project growth.Stran & Company | Investor Presentation Deck | 31 slides · Stran & Company
Pitch deck Investor relations 1 hit
25
The slide uses a timeline framework to demonstrate business growth metrics over time.Stran & Company | Investor Presentation Deck | 31 slides · Stran & Company
Pitch deck Investor relations 1 hit
07
The slide presents interim Phase 1b data from a study by Maurer et al. (EAACI, 2022).Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · Solution1 hit
16
Data presented as Mean ± SD. Logarithmic scale on Y-axis.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations 1 hit
08
Clinical trial data (XP-8121-108) comparing subcutaneous (SC) vs oral (PO) administration.Xeris Biopharma | Investor Presentation Deck | 11 slides · Xeris Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit